NCT02403635View on ClinicalTrials.gov

Drug-Drug Interaction Study: ASP2151 and Midazolam

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

Midazolam

DRUG

ASP2151

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research Ltd, London

All Listed Sponsors
lead

Maruho Europe Limited

INDUSTRY

NCT02403635 - Drug-Drug Interaction Study: ASP2151 and Midazolam | Biotech Hunter | Biotech Hunter